Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
11.55
-0.05 (-0.43%)
At close: May 20, 2026, 4:00 PM EDT
11.45
-0.10 (-0.87%)
After-hours: May 20, 2026, 6:41 PM EDT
Immunic Market Cap
Immunic has a market cap or net worth of $157.33 million as of May 20, 2026. Its market cap has increased by 53.45% in one year.
Market Cap
157.33M
Enterprise Value
-29.15M
1-Year Change
53.45%
Ranking
Category
Stock Price
$11.55
Market Cap Chart
Since April 15, 2019, Immunic's market cap has decreased from $243.61M to $157.33M, a decrease of -35.42%. That is a compound annual growth rate of -5.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 157.33M | 145.08% |
| Dec 31, 2025 | 64.20M | -28.73% |
| Dec 31, 2024 | 90.08M | 33.02% |
| Dec 29, 2023 | 67.72M | 9.04% |
| Dec 30, 2022 | 62.10M | -75.28% |
| Dec 31, 2021 | 251.21M | -20.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elicio Therapeutics | 168.69M |
| Karyopharm Therapeutics | 168.46M |
| Jyong Biotech | 167.64M |
| AN2 Therapeutics | 163.78M |
| Corbus Pharmaceuticals Holdings | 162.29M |
| Heron Therapeutics | 160.53M |
| Acumen Pharmaceuticals | 157.46M |
| TuHURA Biosciences | 156.66M |